Author/Creator: Yu, Ke-Da - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Yu, Ke-Da

1. A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer. Issue 1 (December 2016)

Authors:: Jin, Xi; Jiang, Yi-Zhou; Chen, Sheng; Yu, Ke-Da; Ma, Ding; Sun, Wei; Shao, Zhi-Min; Di, Gen-Hong
Journal:: BMC cancer
Issue:: Volume 16:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Issue 1 (December 2016)

Authors:: Liu, Yi-Rong; Jiang, Yi-Zhou; Xu, Xiao-En; Yu, Ke-Da; Jin, Xi; Hu, Xin; Zuo, Wen-Jia; Hao, Shuang; Wu, Jiong; Liu, Guang-Yu; Di, Gen-Hong; Li, Da-Qiang; He, Xiang-Huo; Hu, Wei-Guo; Shao, Zhi-Ming
Journal:: Breast cancer research
Issue:: Volume 18:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial. (2nd April 2021)

Authors:: Yu, Ke-Da; Ge, Jing-Yu; Liu, Xi-Yu; Mo, Miao; He, Min; Shao, Zhi-Ming
Journal:: Journal of the National Cancer Institute
Issue:: Volume 113:Number 10(2021)
Page Start:: 1352
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer. Issue 1 (December 2015)

Authors:: Yu, Ke-Da; Jiang, Yi-Zhou; Hao, Shuang; Shao, Zhi-Ming
Journal:: BMC medicine
Issue:: Volume 13:Issue 1(2015)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer. (5th November 2020)

Authors:: Ma, Ding; Chen, Si-Yu; Ren, Jin-Xiao; Pei, Yu-Chen; Jiang, Cong-Wei; Zhao, Shen; Xiao, Yi; Xu, Xiao-En; Liu, Guang-Yu; Hu, Xin; Liang, Xiao-Zhen; Yu, Ke-Da; Li, Da-Qiang; Jiang, Yi-Zhou; Shao, Zhi-Ming
Journal:: Journal of the National Cancer Institute
Issue:: Volume 113:Number 7(2021)
Page Start:: 884
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Toll-like receptor 3 -926T>A increased the risk of breast cancer through decreased transcriptional activity. (2nd December 2019)

Authors:: Fan, Lei; Zhou, Peng; Chen, Ao-Xiang; Liu, Guang-Yu; Yu, Ke-Da; Shao, Zhi-Ming
Journal:: Oncoimmunology
Issue:: Volume 8:Number 12(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation. (3rd June 2019)

Authors:: Fan, Lei; Zhou, Peng; Hong, Qi; Chen, Ao-Xiang; Liu, Guang-Yu; Yu, Ke-Da; Shao, Zhi-Ming
Journal:: Oncoimmunology
Issue:: Volume 8:Number 6(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗